Commonwealth Biotechnologies, Inc. Files Chapter 11

Commonwealth Biotechnologies, Inc. (CBTE) announced today that it has filed for reorganization under Chapter 11 bankruptcy in order to complete its planned divestment of assets and subsequent identification of a merger partner in an orderly and efficient way. The process could take up to 12-18 months to complete.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsHealth CareLife Sciences Tools & Services
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!